PMID: 21354377

Geborek A, Hjelte L
Association between genotype and pulmonary phenotype in cystic fibrosis patients with severe mutations.
J Cyst Fibros. 2011 May;10(3):187-92. doi: 10.1016/j.jcf.2011.01.005. Epub 2011 Feb 26., [PubMed]
Sentences
No. Mutations Sentence Comment
95 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 21354377:95:356
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 21354377:95:271
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 21354377:95:321
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 21354377:95:303
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Ser945Leu
X
ABCC7 p.Ser945Leu 21354377:95:88
status: NEW
view ABCC7 p.Ser945Leu details
ABCC7 p.Ser945Leu
X
ABCC7 p.Ser945Leu 21354377:95:172
status: NEW
view ABCC7 p.Ser945Leu details
ABCC7 p.Glu60*
X
ABCC7 p.Glu60* 21354377:95:277
status: NEW
view ABCC7 p.Glu60* details
ABCC7 p.Glu60*
X
ABCC7 p.Glu60* 21354377:95:286
status: NEW
view ABCC7 p.Glu60* details
ABCC7 p.Trp79Arg
X
ABCC7 p.Trp79Arg 21354377:95:339
status: NEW
view ABCC7 p.Trp79Arg details
Class I/class I Class I/class II Class II/class II 1717-1 G-NA/1717-1 G-NA n=1 3659delC/S945L n=1 F508del/F508del n=165 3659delC/3659delC n=5 3659delC/F508del n=23 F508del/S945L n=5 3659delC/394delTT n=7 394delTT/F508del n=38 394delTT/394delTT n=4 621+1 G-NT/F508del n=6 R553X/E60X n=1 E60X/F508del n=4 G542X/F508del n=1 R553X/F508del n=2 W79R/F508del n=1 W1282X/F508del n=1 1717-1 G-NA/F508del n=1 Total 18 78 170 The other class combinations are not shown. Login to comment
98 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 21354377:98:64
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 21354377:98:148
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 21354377:98:209
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 21354377:98:154
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 21354377:98:142
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 21354377:98:198
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 21354377:98:106
status: NEW
view ABCC7 p.Arg560Thr details
ABCC7 p.Ser945Leu
X
ABCC7 p.Ser945Leu 21354377:98:100
status: NEW
view ABCC7 p.Ser945Leu details
ABCC7 p.Arg117Cys
X
ABCC7 p.Arg117Cys 21354377:98:112
status: NEW
view ABCC7 p.Arg117Cys details
ABCC7 p.Glu60*
X
ABCC7 p.Glu60* 21354377:98:193
status: NEW
view ABCC7 p.Glu60* details
ABCC7 p.Trp79Arg
X
ABCC7 p.Trp79Arg 21354377:98:204
status: NEW
view ABCC7 p.Trp79Arg details
Class I Class II Class III Class IV Class V 1717-1 G-NA F508del G551D 297 C-NA 2789+5 G-NA 3659delC S945L R560T R117C 3849+10 kb CNT 394delTT R347P A455E R553X T 3381 3849+10 kb C-T 621+1 G-NT E60X G542X W79R W1282X decline of pulmonary function was more rapid in patients with pancreatic insufficiency, mainly class II mutations, compared to CF patients with normal pancreatic function [4]. Login to comment